Phase 3 Pancreatic Cancer Trial, Recruiting NCT07621718 Sponsor: Revolution Medicines, Inc. Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Phase 3 Pancreatic Cancer Trial, Recruiting

NCT07621718
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are at least 18 years old and have agreed to take part by signing a consent form.
  • Your general health and ability to carry out daily activities is rated as good or fully active (confirm with trial site for exact rating details).
  • Your cancer has been confirmed through a tissue or cell sample to be pancreatic adenocarcinoma (a specific type of pancreatic cancer).
  • You were diagnosed with cancer that has spread to other parts of the body no more than 6 weeks before the screening visit.
  • Your cancer has been tested and has a specific gene change called KRAS G12D.
  • Your cancer can be measured on scans according to standard guidelines.
  • Your bone marrow, liver, kidneys, and blood clotting are all working well enough (confirm with trial site for specific levels required).
  • You are able to swallow and take oral (by mouth) medications.

Who may not be able to join:

  • You have already received cancer treatment given throughout the body (such as chemotherapy) for pancreatic cancer that could not be removed by surgery or has spread.
  • You have ever received any treatment specifically targeting a gene called RAS at any point before joining the trial.
  • Your cancer is driven by a different known gene change that already has an approved targeted treatment available.
  • You have cancer that has spread to the brain or spinal cord, or have a history of this that has not been treated.
  • You have any health condition that might affect your ability to swallow, absorb, or tolerate the study medication.
  • You have had a major operation within 28 days before joining the trial.
  • You are unwilling or unable to attend the required study visits or follow the trial procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 1-844-2-REVMED

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Revolution Medicines, Inc.
Registry
ClinicalTrials.gov
Start date
22 May 2026
Est. completion
30 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Progression free survival (PFS); Overall survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov